Regeneron Pharmaceuticals, Inc. (REGN)
930.74
-42.62
(-4.38%)
USD |
NASDAQ |
Nov 04, 16:00
930.74
0.00 (0.00%)
After-Hours: 16:28
Regeneron Pharmaceuticals Total Return Price : 930.74 for Nov. 4, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| November 03, 2026 | 973.36 |
| November 02, 2026 | 961.26 |
| October 30, 2026 | 927.89 |
| October 29, 2026 | 818.77 |
| October 28, 2026 | 813.27 |
| October 27, 2026 | 816.10 |
| October 26, 2026 | 807.67 |
| October 23, 2026 | 805.02 |
| October 22, 2026 | 819.09 |
| October 21, 2026 | 805.67 |
| October 20, 2026 | 807.48 |
| October 19, 2026 | 782.04 |
| October 16, 2026 | 790.74 |
| October 15, 2026 | 796.34 |
| October 14, 2026 | 778.36 |
| October 13, 2026 | 753.12 |
| October 12, 2026 | 762.81 |
| October 09, 2026 | 746.54 |
| October 08, 2026 | 739.57 |
| October 07, 2026 | 742.12 |
| October 06, 2026 | 738.72 |
| October 05, 2026 | 726.47 |
| October 02, 2026 | 735.20 |
| October 01, 2026 | 734.81 |
| September 30, 2026 | 758.27 |
| Date | Value |
|---|---|
| September 29, 2026 | 750.51 |
| September 28, 2026 | 752.25 |
| September 25, 2026 | 788.04 |
| September 24, 2026 | 796.02 |
| September 23, 2026 | 801.82 |
| September 22, 2026 | 803.90 |
| September 21, 2026 | 798.17 |
| September 18, 2026 | 784.85 |
| September 17, 2026 | 789.45 |
| September 16, 2026 | 774.61 |
| September 15, 2026 | 774.11 |
| September 14, 2026 | 793.74 |
| September 11, 2026 | 781.49 |
| September 10, 2026 | 793.26 |
| September 09, 2026 | 807.65 |
| September 08, 2026 | 810.31 |
| September 04, 2026 | 827.72 |
| September 03, 2026 | 843.47 |
| September 02, 2026 | 852.03 |
| September 01, 2026 | 823.82 |
| August 31, 2026 | 799.08 |
| August 28, 2026 | 794.19 |
| August 27, 2026 | 807.71 |
| August 26, 2026 | 814.79 |
| August 25, 2026 | 833.56 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| AbbVie, Inc. | 294.77 |
| Amgen, Inc. | 478.34 |
| Incyte Corp. | 122.91 |
| Vertex Pharmaceuticals, Inc. | 549.06 |
| Gilead Sciences, Inc. | 174.45 |